Paperpal Prime Logo

Thrombosis Journal : Impact Factor & More

eISSN: 1477-9560pISSN: 1477-9560
JournalOpen Access

Key Metrics

CiteScore
4.8
Impact Factor
< 5
SJR
Q2Hematology
SNIP
1.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Thrombosis Journal

Thrombosis Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 1990
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Thrombosis Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Thrombosis Journal

Anticoagulation-associated hemorrhage in atrial fibrillation as a marker of occult malignancy: a narrative review
  • 13 Oct 2026
  • Thrombosis Journal
A D-dimer-, platelet count-, and albumin-based model for predicting 30-day central venous catheter-related thrombosis in patients with malignancy: a single-center retrospective cohort study
  • 13 Oct 2026
  • Thrombosis Journal
Integrated scRNA-seq and spatial transcriptomics identify caveolin-1 as a regulator of endothelial progenitor cell function associated with PI3K/AKT signalling and DVT recanalization
  • 6 Oct 2026
  • Thrombosis Journal
Age-dependent patterns of D-dimer and APTT for VTE in severe pneumonia: a multicenter retrospective study.
  • 6 Oct 2026
  • Thrombosis journal
Correction: Underlying thrombotic conditions in patients with splenic infarction: a 10-year retrospective analysis
  • 5 Oct 2026
  • Thrombosis Journal
Genistein preferentially inhibits collagen-induced platelet aggregation by suppressing granule secretion involving PI3K/Akt signaling in human platelets
  • 29 Sep 2026
  • Thrombosis Journal
Anticoagulation-associated hemorrhage in atrial fibrillation as a marker of occult malignancy: a narrative review
  • 13 Oct 2026
  • Thrombosis Journal
A D-dimer-, platelet count-, and albumin-based model for predicting 30-day central venous catheter-related thrombosis in patients with malignancy: a single-center retrospective cohort study
  • 13 Oct 2026
  • Thrombosis Journal
Integrated scRNA-seq and spatial transcriptomics identify caveolin-1 as a regulator of endothelial progenitor cell function associated with PI3K/AKT signalling and DVT recanalization
  • 6 Oct 2026
  • Thrombosis Journal
Age-dependent patterns of D-dimer and APTT for VTE in severe pneumonia: a multicenter retrospective study.
  • 6 Oct 2026
  • Thrombosis journal
Correction: Underlying thrombotic conditions in patients with splenic infarction: a 10-year retrospective analysis
  • 5 Oct 2026
  • Thrombosis Journal
Genistein preferentially inhibits collagen-induced platelet aggregation by suppressing granule secretion involving PI3K/Akt signaling in human platelets
  • 29 Sep 2026
  • Thrombosis Journal

FAQs on Thrombosis Journal